GlassScriptPhysician profile
Heather M Manos
NPI 1427186022
$2,501.01
in general payments reported to CMS, 2019-2025
40 companies · $525 in 2025
The $525 reported for 2025 was more than what 81% of Addiction Medicine (Family Medicine) providers received nationally (typical 2025 total: $143).
See the full distribution for Addiction Medicine (Family Medicine)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $36.09 · 2020: $135 · 2021: $260 · 2022: $291 · 2023: $887 · 2024: $367 · 2025: $525.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,752 · Education: $27.27.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,751.79 |
| Education | $27.27 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Indivior INC. | $331.35 | 2019-2025 | Sublocade |
| Viiv Healthcare Company | $178.56 | 2023-2025 | Apretude, Rukobia |
| Braeburn INC. | $159.01 | 2023-2024 | Brixadi |
| Abbvie INC. | $154.49 | 2023-2025 | |
| Alkermes, INC. | $149.23 | 2020-2025 | Vivitrol |
| Amgen INC. | $145.09 | 2022-2025 | |
| Gilead Sciences, INC. | $120.97 | 2021-2024 | |
| Mdd US Operations, LLC | $119.26 | 2020 | |
| Uswm, LLC | $106.60 | 2022-2023 | Lucemyra, Zimhi |
| Napo Pharmaceuticals INC | $89.82 | 2023 | Mytesi |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $67.49 | 2025 | Caplyta |
| Novo Nordisk INC | $67.17 | 2021-2024 | Ozempic, Rybelsus |
| E.R. Squibb & Sons, L.L.C. | $66.79 | 2025 | Cobenfy |
| Novartis Pharmaceuticals Corporation | $61.77 | 2023 | |
| Antares Pharma, INC. | $60.37 | 2021-2022 |
Show all 40 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Heather Manos listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.